Back
Regeneron Pharmaceuticals Stock Predictions
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
REGN
Regeneron Pharmaceuticals
Last Price:
$616.55
Seasonality Move:
3.82%
7 Day Trial
ALL ACCESS PASS
$
7
AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31.6% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $617.00. The Score for REGN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31.6% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
30
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
618.51
Prediction Charts
Market Cap:
67.5B
Price in USD:
617.00
Volume:
1.1M
Beta:
0.95
Technical Analysis
SMA50:
680.14
SMA100:
716.17
SMA200:
894.79
52-Wk Change:
-36.35%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 617.00 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-13 | 687.43 | 680.61 | 698.95 | 677.34 |
| Mar-14 | 680.61 | 666.87 | 686.98 | 657.00 |
| Mar-17 | 668.26 | 678.42 | 679.83 | 664.68 |
| Mar-18 | 678.00 | 664.96 | 678.27 | 664.30 |
| Mar-19 | 663.67 | 672.36 | 674.57 | 659.03 |
| Mar-20 | 670.00 | 662.62 | 674.83 | 662.33 |
| Mar-21 | 658.00 | 658.48 | 661.00 | 651.06 |
| Mar-24 | 660.00 | 661.00 | 667.46 | 655.30 |
| Mar-25 | 662.45 | 634.14 | 662.57 | 633.10 |
| Mar-26 | 634.14 | 640.14 | 644.00 | 629.02 |
| Mar-27 | 641.21 | 635.83 | 643.43 | 629.94 |
| Mar-28 | 638.01 | 637.36 | 642.97 | 631.45 |
| Mar-31 | 630.08 | 634.23 | 640.72 | 618.51 |
| Apr-1 | 630.51 | 617.00 | 641.24 | 615.00 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.28 per share, a decrease this year of $2.45 per share, and an increase next year of $4.48 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.